Dąbrowski M. In whom and why a dual-analog insulin aspart + degludec is worth to be used?. J EBM [Internet]. 2023Jun.30 [cited 2026Nov.13];16(2(59):227-33. Available from: https://www.journalsmededu.pl/index.php/jebm/article/view/2839